Lung Cancer Research Foundation
Eligibility
- Must be no more than 7 years into first faculty appointment.
- Postdoctoral researchers and fellows are eligible.
Description
Grants focus on furthering the understanding of the development, prevention, and therapy of resistance by supporting projects that seek to identify, characterize, treat or prevent resistance to lung cancer therapies. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer and across the care continuum including newly designed targeted therapies and immunotherapies.
Award Note
2 years
Anticipated Deadline: March 2027
Keywords:
lung cancer, biology, immunotherapy, palliative care, telemedicine, genetic, biomarker, machine learning, AI, theragnostic, biomaterials, nanotechnology, controlled-drug release, gene therapy, genomics, histology, epidemiology, risk factors, prevention, technologies
Award amount:
$150,000